Tracers / [18F]AlF-3p-C-NETA-TATE

[18F]AlF-3p-C-NETA-TATE

Also written as [18F]AlF-3p-C-NETA-TATE; [F-18]AlF-3p-C-NETA-TATE

Radionuclide: F-18 t½ 109.77 min
Modality: PET
Production route: —
Stage: preclinical study
Syntheses indexed: 2

Preclinical only, no clinical indication yet

What it is

Compound class: Radiolabeled somatostatin analogue (3p-C-NETA-TATE, chelator-linker-octreotate peptide conjugate)
Target / mechanism: Somatostatin receptor targeting (TATE/octreotate analogue) PMID 35966589
Clinical application: —
Theranostic pair: —

Regulatory status

FDA: —
EMA (centralised): —
Other approvals: —
Brand names: —

Clinical use

Typical injected activity: —
Uptake time: —

Reported in the literature. Not a dosing recommendation.

Published syntheses

Module	Cassette	Purification	Yield %	RCP %	Precursor / supplier	Source
AllinOne (AiO) Trasis	—	HPLC	41.4 ± 8% yes	>97%	3p-C-NETA-TATE	35966589 2022 Theranostics [18F]AlF-3p-C-NETA-TATE was synthesized in an automated AllinOne® synthesis module (Trasis, Liège, Belgium) — the corresponding [18F]AlF-3p-C-NETA-TATE was obtained in good RCY [(41.4 ± 8%, (decay-corrected, activity final batch of purified product/activity in reactor, n = 8, apparent molar activity 22 ± 8 GBq/μmol)]
AllinOne (AiO) Trasis	—	HPLC	41.4 ± 8% yes	>97%	3p-C-NETA-TATE	35966589 2022 Theranostics [18F]AlF-3p-C-NETA-TATE was synthesized in an automated AllinOne® synthesis module (Trasis, Liège, Belgium) — [18F]AlF-3p-C-NETA-TATE was obtained in good RCY [(41.4 ± 8%, (decay-corrected, activity final batch of purified product/activity in reactor, n = 8, apparent molar activity 22 ± 8 GBq/μmol)]

Need this precursor?We can point you to suppliers for [18F]AlF-3p-C-NETA-TATE, or handle the enquiry for you.

Get in touch

Quality control Preliminary — inferred from compound class

Ph. Eur. monograph: —
USP monograph: —

AppearancepHRCP HPLCRCP TLCHPLC UVRadionuclidic (HPGe)Half-lifeActivityEndotoxins (LAL)SterilityFilter integrityMolar activity

How this set was arrived at. base set per Ph. Eur. general monograph 0125 (rule); receptor ligand with a saturable target -> molar activity (rule); organic-phase radiosynthesis assumed from isotope/compound class, no synthesis data confirming it -> GC residual solvents (preliminary)

Tests listed by reference only. Monograph texts are copyrighted and are not reproduced here. How these are derived

Setting up quality control?We can help you scope the equipment needed to release [18F]AlF-3p-C-NETA-TATE.

Get in touch

Notes

Added from reverse module search (stage 6); 2 article(s) with F-18. Compound class inferred from precursor name (not stated outright) -- PMID 35966589: '3p-C-NETA-TATE'. Stage set/updated at stage 23 from PMID 35966589: 'In this study we evaluated 3p-C-NETA, as potential theranostic Al18F-chelator and present first results of radiosynthesis and preclinical evaluation of [18F]AlF-3p-C-NETA-TATE.'.